Study of AT-527 in Healthy and HCV-Infected Subjects
Clinical trial NCT03219957 · COMPLETED
Trial details
- NCT number
- NCT03219957
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-06
- Primary completion
- 2018-06-20
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.